Ewa Siwak

577 total citations
24 papers, 372 citations indexed

About

Ewa Siwak is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Ewa Siwak has authored 24 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Emergency Medicine. Recurrent topics in Ewa Siwak's work include HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (6 papers) and HIV-related health complications and treatments (6 papers). Ewa Siwak is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (6 papers) and HIV-related health complications and treatments (6 papers). Ewa Siwak collaborates with scholars based in Poland, United States and Germany. Ewa Siwak's co-authors include Alicja Wiercińska‐Drapało, Iwona Cielniak, Andrzej Horban, Joanna Pogorzelska, Jerzy Jaroszewicz, D Prokopowicz, Hervé Porchet, Jean‐Maurice Dumont, Jarosław Kierkuś and Piétro Scalfaro and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Ewa Siwak

22 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Siwak Poland 9 157 137 117 111 58 24 372
Kazuhiko Ikeuchi Japan 10 129 0.8× 38 0.3× 115 1.0× 142 1.3× 26 0.4× 40 368
C. Smacchia Italy 8 138 0.9× 35 0.3× 39 0.3× 118 1.1× 43 0.7× 10 400
Suzanne Fiorillo United States 11 110 0.7× 20 0.1× 109 0.9× 137 1.2× 58 1.0× 19 386
Stacey Chapman United States 9 176 1.1× 146 1.1× 35 0.3× 147 1.3× 98 1.7× 14 329
Elena Rastrelli Italy 8 90 0.6× 36 0.3× 43 0.4× 111 1.0× 43 0.7× 15 453
Arício Treitinger Brazil 15 338 2.2× 229 1.7× 27 0.2× 136 1.2× 55 0.9× 32 532
Ralph‐Sydney Mboumba Bouassa France 12 217 1.4× 23 0.2× 29 0.2× 193 1.7× 84 1.4× 38 382
Samuel Adeniyi‐Jones United States 11 158 1.0× 37 0.3× 148 1.3× 203 1.8× 93 1.6× 15 478
Anna Maria Iorio Italy 13 344 2.2× 45 0.3× 96 0.8× 102 0.9× 34 0.6× 22 654
Massimo Giola Italy 9 87 0.6× 43 0.3× 29 0.2× 75 0.7× 11 0.2× 15 294

Countries citing papers authored by Ewa Siwak

Since Specialization
Citations

This map shows the geographic impact of Ewa Siwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Siwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Siwak more than expected).

Fields of papers citing papers by Ewa Siwak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Siwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Siwak. The network helps show where Ewa Siwak may publish in the future.

Co-authorship network of co-authors of Ewa Siwak

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Siwak. A scholar is included among the top collaborators of Ewa Siwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Siwak. Ewa Siwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serwin, Karol, Anna Urbańska, Ewa Siwak, et al.. (2024). Phylodynamic evolution of HIV‐1 A6 sub‐subtype epidemics in Poland. Journal of Medical Virology. 96(2). e29482–e29482. 6 indexed citations
2.
Serwin, Karol, Antoine Chaillon, Anna Urbańska, et al.. (2023). Circulation of Human Immunodeficiency Virus 1 A6 Variant in the Eastern Border of the European Union—Dynamics of the Virus Transmissions Between Poland and Ukraine. Clinical Infectious Diseases. 76(10). 1716–1724. 15 indexed citations
3.
Załęski, Andrzej, et al.. (2023). Changes in Primary HIV-1 Drug Resistance Due to War Migration from Eastern Europe. Journal of Immigrant and Minority Health. 26(1). 15–22. 5 indexed citations
4.
Kowalska, Justyna, Elżbieta Jabłonowska, Ewa Siwak, et al.. (2022). Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland. Infection. 51(2). 379–387. 4 indexed citations
5.
6.
Siwak, Ewa, et al.. (2022). Inflammatory Bowel Disease in Adult HIV-Infected Patients-Is Sexually Transmitted Infections Misdiagnosis Possible?. Journal of Clinical Medicine. 11(18). 5324–5324. 4 indexed citations
7.
Jabłonowska, Elżbieta, Ewa Siwak, Monika Bociąga‐Jasik, et al.. (2019). Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients. PLoS ONE. 14(1). e0210476–e0210476. 10 indexed citations
8.
Gökengin, Deniz, Inka Aho, Ewa Siwak, et al.. (2019). Exposure to dolutegravir in pregnant women living with HIV in Central and Eastern Europe and neighboring countries — data from the ECEE Network Group. Ginekologia Polska. 90(7). 411–415. 1 indexed citations
9.
Parczewski, Miłosz, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska, et al.. (2018). Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters. Clinical Microbiology and Infection. 25(4). 513.e1–513.e6. 3 indexed citations
10.
Jabłonowska, Elżbieta, Jacek Gąsiorowski, Miłosz Parczewski, et al.. (2017). Efficacy and safety of nucleoside‐sparing regimen based on raltegravir and ritonavir‐boosted darunavir in HIV‐1‐infected treatment‐experienced patients. Journal of Medical Virology. 89(12). 2122–2129. 9 indexed citations
11.
Jabłonowska, Elżbieta, Jacek Gąsiorowski, Miłosz Parczewski, et al.. (2016). Dual therapy based on raltegravir and boosted protease inhibitors – the experience of Polish centers. Archives of Medical Science. 14(4). 860–864. 2 indexed citations
12.
Kowalska, Justyna, et al.. (2016). Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients. AIDS Research and Therapy. 13(1). 2–2. 11 indexed citations
13.
14.
Firląg‐Burkacka, Ewa, Iwona Cielniak, Ewa Siwak, et al.. (2015). High frequency of neurosyphilis in HIV‐positive patients diagnosed with early syphilis. HIV Medicine. 17(5). 323–326. 19 indexed citations
15.
Firląg‐Burkacka, Ewa, Iwona Cielniak, Ewa Siwak, et al.. (2013). The increasing prevalence of neurosyphilis and high serum VDRL titers in HIV positive patients—Data from outpatient clinic in Warsaw, Poland (POLCA Cohort). HIV & AIDS Review. 12(2). 34–36. 4 indexed citations
16.
Wiercińska‐Drapało, Alicja, Jerzy Jaroszewicz, Ewa Siwak, Joanna Pogorzelska, & D Prokopowicz. (2008). Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regulatory Peptides. 147(1-3). 25–28. 68 indexed citations
17.
Flisiak, Robert, Andrzej Horban, Philippe Gallay, et al.. (2008). The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology. 47(3). 817–826. 179 indexed citations
18.
Pogorzelska, Joanna, et al.. (2007). [Tuberculosis and HIV infection--main diagnostic and therapeutic problems].. PubMed. 23(135). 212–4. 3 indexed citations
19.
Wiercińska‐Drapało, Alicja, et al.. (2007). Serum concentrations of α-defensins in patients with different stages of HIV-infection. HIV & AIDS Review. 6(4). 20–22. 1 indexed citations
20.
Siwak, Ewa, et al.. (1994). [Changes in ECG examination of patients with trichinosis].. PubMed. 47(13-14). 499–502. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiko Ikeuchi Breakdown of academic impact, for papers by C. Smacchia Breakdown of academic impact, for papers by Suzanne Fiorillo Breakdown of academic impact, for papers by Stacey Chapman Breakdown of academic impact, for papers by Elena Rastrelli Breakdown of academic impact, for papers by Arício Treitinger Breakdown of academic impact, for papers by Ralph‐Sydney Mboumba Bouassa Breakdown of academic impact, for papers by Samuel Adeniyi‐Jones Breakdown of academic impact, for papers by Anna Maria Iorio Breakdown of academic impact, for papers by Massimo Giola
Rankless by CCL
2026